The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab plus chemotherapy (bev/CT) as first-line therapy for patients with potentially resectable metastatic colorectal cancer (mCRC): Final results of the French noninterventional PICASSO study.
 
David Malka
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Jean-Philippe Metges
Honoraria - Bayer; Merck; Roche; Sanofi
 
Dominique Elias
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Franck Bonnetain
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; IntegraGen; invectys; Merck Serono; NESTLE; Novartis; Roche
Research Funding - Roche (Inst)
 
Louis-Marie Dourthe
No Relationships to Disclose
 
Meher Ben Abdelghani
Consulting or Advisory Role - Ipsen; Sanofi
 
Abderraouf Radji
No Relationships to Disclose
 
Philippe Laplaige
Honoraria - Genomic Health; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Genomic Health; Pierre Fabre; Roche; Sanofi
 
Fabien Petit Laurent
No Relationships to Disclose
 
Vanessa Barue
Employment - Roche
 
Sophie Gandon
Employment - Roche
 
Michel Rivoire
No Relationships to Disclose